Education
About Us
Working with TipRanks
Follow Us
Dr. Lal PathLabs Limited (IN:LALPATHLAB)
:LALPATHLAB
Total Valuation
Dr. Lal PathLabs Limited has a market cap or net worth of ₹264.07B. The enterprise value is ₹197.17B.
Market Cap₹264.07B
Enterprise Value₹197.17B
Share Statistics
Dr. Lal PathLabs Limited has 83,775,510 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding83,775,510
Owned by Insiders―
Owned by Institutions0.08%
Financial Efficiency
Dr. Lal PathLabs Limited’s return on equity (ROE) is 0.22 and return on invested capital (ROIC) is 31.62%.
Return on Equity (ROE)0.22
Return on Assets (ROA)0.18
Return on Invested Capital (ROIC)31.62%
Return on Capital Employed (ROCE)0.42
Revenue Per Employee6.00M
Profits Per Employee1.19M
Employee Count4,099
Asset Turnover0.91
Inventory Turnover28.73
Valuation Ratios
The current PE Ratio of Dr. Lal PathLabs Limited is 49.2. Dr. Lal PathLabs Limited’s PEG ratio is 1.15.
PE Ratio49.2
PS Ratio8.13
PB Ratio9.21
Price to Fair Value9.21
Price to FCF38.16
Price to Operating Cash Flow0.00
PEG Ratio1.15
Income Statement
In the last 12 months, Dr. Lal PathLabs Limited had revenue of 24.61B and earned 4.87B in profits. Earnings per share was 58.48.
Revenue24.61B
Gross Profit14.24B
Operating Income9.73B
Pretax Income6.25B
Net Income4.87B
EBITDA6.58B
Earnings Per Share (EPS)58.48
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Dr. Lal PathLabs Limited pays an annual dividend of ₹7, resulting in a dividend yield of 0.8%
Dividend Per Share₹7
Dividend Yield0.8%
Payout Ratio42.17%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.51
52-Week Price Change4.57%
50-Day Moving Average3.16K
200-Day Moving Average2.92K
Relative Strength Index (RSI)48.01
Average Volume (3m)3.61K
Important Dates
Dr. Lal PathLabs Limited upcoming earnings date is Jan 29, 2026, TBA (Confirmed).
Last Earnings DateOct 31, 2025
Next Earnings DateJan 29, 2026
Ex-Dividend DateNov 07, 2025
Financial Position
Dr. Lal PathLabs Limited as a current ratio of 3.39, with Debt / Equity ratio of 0.00%
Current Ratio3.39
Quick Ratio3.30
Debt to Market Cap<0.01
Net Debt to EBITDA-0.21
Interest Coverage Ratio43.63
Taxes
In the past 12 months, Dr. Lal PathLabs Limited has paid 1.33B in taxes.
Income Tax1.33B
Effective Tax Rate0.21
Enterprise Valuation
Dr. Lal PathLabs Limited EV to EBITDA ratio is 30.21, with an EV/FCF ratio of 37.90.
EV to Sales8.08
EV to EBITDA30.21
EV to Free Cash Flow37.90
EV to Operating Cash Flow34.95
Balance Sheet
Dr. Lal PathLabs Limited has ₹11.64B in cash and marketable securities with ₹0.00 in debt, giving a net cash position of ₹11.64B billion.
Cash & Marketable Securities₹11.64B
Total Debt₹0.00
Net Cash₹11.64B
Net Cash Per Share₹138.95
Tangible Book Value Per Share₹168.71
Margins
Gross margin is 57.99%, with operating margin of 39.53%, and net profit margin of 19.79%.
Gross Margin57.99%
Operating Margin39.53%
Pretax Margin25.38%
Net Profit Margin19.79%
EBITDA Margin26.73%
EBIT Margin22.72%
Analyst Forecast
The average price target for Dr. Lal PathLabs Limited is ―, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target―
Price Target Upside―
Analyst ConsensusModerate Buy
Analyst Count0
Revenue Growth Forecast10.80%
EPS Growth Forecast32.79%